by Entheogen Biomedical | Dec 4, 2020 | Company News
Originally published at https://www.newsfilecorp.com/release/69518 Vancouver, BC – December 4, 2020 – Entheon Biomedical Corp. (CSE: “ENBI”) (FSE:1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat...
by Entheogen Biomedical | Dec 1, 2020 | Company News
Centre for Human Drug Research led DMT study to start in 2021 Vancouver, BC – December 1, 2020 – Entheon Biomedical Corp. (“Entheon” or the “Company”) (CSE: ENBI) (FSE: 1XU1), a biotechnology company focused on developing psychedelic medicines to treat...
Recent Comments